Latest blog articles
-
M-EPLI was delighted to have Professor Vanessa Mak in Maastricht to discuss her research on consumer law and policy at the M-EPLI Talk on February 6th.
-
The IMCO Committee is trying to amend the Unfair Commercial Practices Directive (2005/29) to include a ban on dark patterns. The proposed amendments are part of the EU’s plans to empower consumers for the green transition and the Parliament is expected to address the proposed amendments on 17 April...
-
Over the weekend of March 25-26, TikTok users started sharing videos of their experiences trying to delete their Instagram accounts on Android devices. Users took issue with not being able to delete their accounts via the Instagram app and having to use a desktop/mobile browser to complete the...
-
How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.
-
It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...
-
The development of Genetically Modified Organisms (GMOs), nanotechnology and neonicotinoid insecticides presents opportunities for humans and the environment, but it can also carry risks to human, animal or plant health.
-
Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...